Author: digi

Metered-Dose Inhalers: GMP Controls for Valve Performance and Dose Reproducibility Metered-Dose Inhalers: GMP Controls for Valve Performance and Dose Reproducibility Metered-dose inhalers (MDIs) represent a critical dosage form in pharmaceutical manufacturing, serving delivery of respiratory medicines with precise dosing and patient-friendly administration. As combination products involving drug substances, formulation excipients, and complex device components such…

Read More “Metered-Dose Inhalers: GMP Controls for Valve Performance and Dose Reproducibility” »

Dry Powder Inhalers: Powder Flow, Humidity Control and Device GMP in Pharmaceutical Manufacturing Comprehensive GMP Approach to Dry Powder Inhalers: Managing Powder Flow, Humidity, and Device Quality Dry powder inhalers (DPIs) represent a critical segment of inhalation products pivotal to respiratory therapy worldwide. Ensuring the quality of DPIs requires specialized Good Manufacturing Practice (GMP) adherence…

Read More “Dry Powder Inhalers: Powder Flow, Humidity Control and Device GMP” »

Nebulizer Solutions and Suspensions: Sterility, Preservatives and Device Interface Nebulizer Solutions and Suspensions: Ensuring Sterility, Preservative Efficacy, and Device Compatibility under GMP The manufacturing, quality assurance, and regulatory compliance of nebulizer solutions and suspensions present unique challenges within pharmaceutical Good Manufacturing Practice (GMP) frameworks. These inhalation products must fulfill stringent criteria for sterility, preservative integrity,…

Read More “Nebulizer Solutions and Suspensions: Sterility, Preservatives and Device Interface” »

Viral Vector and Gene Therapy Drug Products: ATMP-Specific GMP Challenges Viral Vector and Gene Therapy Drug Products: Navigating ATMP-Specific GMP Challenges Advanced Therapy Medicinal Products (ATMPs), such as viral vector-based gene therapies, present unique challenges in Good Manufacturing Practice (GMP) compliance. Due to their complex and sensitive nature, these drug products must adhere to stringent…

Read More “Viral Vector and Gene Therapy Drug Products: ATMP-Specific GMP Challenges” »

Ophthalmic Product GMP: Particulate, pH and Osmolality Critical Controls Ophthalmic Product GMP: Particulate, pH and Osmolality Critical Controls in Dosage Forms The manufacturing of ophthalmic pharmaceutical products demands rigorous compliance with Good Manufacturing Practice (GMP) requirements specific to dosage forms. These products, being highly sensitive formulations administered directly to the eye, require strict control over…

Read More “Ophthalmic Product GMP: Particulate, pH and Osmolality Critical Controls” »

Multi-Dose Ophthalmic Products: Preservative Efficacy and Microbial Limits Multi-Dose Ophthalmic Products: Ensuring Preservative Efficacy and Controlling Microbial Limits In the pharmaceutical production of multidose ophthalmic products, addressing preservative efficacy and establishing appropriate microbial limits are of paramount importance to meet stringent GMP requirements across the US, UK, and EU markets. These products present unique microbiological…

Read More “Multi-Dose Ophthalmic Products: Preservative Efficacy and Microbial Limits” »

Blow–Fill–Seal (BFS) Technology: GMP Controls for Ophthalmic and Inhalation Products GMP Controls for Blow–Fill–Seal (BFS) Technology in Ophthalmic and Inhalation Products: A Step-by-Step Guide Pharmaceutical manufacturers operating within the US, UK, and European Union must sustain rigorous quality standards across diverse dosage forms such as solid oral, parenteral, and topical products. Among sterilization and aseptic…

Read More “Blow–Fill–Seal (BFS) Technology: GMP Controls for Ophthalmic and Inhalation Products” »

Nasal Sprays and Drops: GMP Controls for Delivered Dose and Spray Pattern GMP Controls for Delivered Dose and Spray Pattern in Nasal Sprays and Drops: A Step-by-Step Guide The pharmaceutical industry continually evolves with diversified dosage forms, including solid oral preparations, parenteral injections, and topical products. Among topical dosage forms, nasal sprays and drops occupy…

Read More “Nasal Sprays and Drops: GMP Controls for Delivered Dose and Spray Pattern” »

GMP for Lyophilized Products: Cake Appearance, Residual Moisture and Reconstitution Comprehensive GMP Guide for Lyophilized Products: Cake Appearance, Residual Moisture, and Reconstitution Lyophilized products, often referred to as freeze-dried pharmaceuticals, represent a critical dosage form within the sterile parenteral manufacturing sphere. Their unique requirements under Good Manufacturing Practice (GMP) guidelines demand precise control over formulation,…

Read More “GMP for Lyophilized Products: Cake Appearance, Residual Moisture and Reconstitution” »

Handling and Filling of Highly Viscous or Sensitive Injectable Solutions: GMP Best Practices Step-by-Step Guide for Handling and Filling Highly Viscous or Sensitive Injectable Solutions Under GMP Within the pharmaceutical manufacturing landscape, the production of parenteral dosage forms—specifically highly viscous or sensitive injectable solutions—poses unique challenges. These products require strict adherence to Good Manufacturing Practice…

Read More “Handling and Filling of Highly Viscous or Sensitive Injectable Solutions” »